Strategic Exhibit Guard Medical has gained industry recognition with the 2024 AAHKS Industry Innovation Award for NPseal, signaling strong validation from key surgical specialties and potential for expansion into hospitals and private clinics focused on orthopedic wound care.

Clinical Validation NPseal offers battery-free, tube-free negative pressure wound therapy for closed incisions, highlighting a compelling value proposition for perioperative care teams seeking easier-to-use, cost-effective NPWT solutions that can reduce infection risk and improve healing.

Regulatory Momentum A track record of FDA 510(k) clearances since 2020 with wear-time extensions and additional sizes positions Guard Medical for accelerated adoption across diverse surgical procedures and facilities needing scalable NPWT options.

Growth Financing Recent Series B funding and ongoing revenue indicate investor confidence and capital available for strategic partnerships, national sales expansion, and hospital deployments in orthopedic, general surgery, and wound-care markets.

Tech-Enabled Outreach A modern digital stack (AWS, Adobe Experience Manager, Webflow, WordPress, CRM-ready tools) combined with a targeted online presence can support direct-to-hospital outreach, distributor partnerships, and education campaigns to drive adoption.